Literature DB >> 20537409

Orchestrating innate immune responses in multiple sclerosis: molecular players.

Marta Fernández1, Xavier Montalban, Manuel Comabella.   

Abstract

Innate immunity is the body's first line of defense against foreign pathogens. Although adaptive immune responses have for long time been considered to play important roles in the etiopathogenesis of autoimmune disorders such as multiple sclerosis (MS), evidence exists that adaptive immunity is not acting in isolation but rather in conjunction with components of the innate immune system. In fact, innate immune responses influence the nature of adaptive immune responses, and many components of innate immunity are used by adaptive immunity as effectors. In this review, we will focus on the role of key players of the innate immune system, including Toll-like receptors, the complement system and cytokines, on MS and its animal model, experimental autoimmune encephalomyelitis. We discuss in vitro and in vivo experimental data showing that the interaction mechanisms operating between adaptive and innate immune systems should be considered to better understand disease etiopathogenesis and the effect of therapies targeting components of the innate immune system. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537409     DOI: 10.1016/j.jneuroim.2010.05.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 2.  Toll-like receptors are key players in neurodegeneration.

Authors:  Daniela S Arroyo; Javier A Soria; Emilia A Gaviglio; Maria C Rodriguez-Galan; Pablo Iribarren
Journal:  Int Immunopharmacol       Date:  2011-05-25       Impact factor: 4.932

Review 3.  The immunopathophysiology of multiple sclerosis.

Authors:  Gregory F Wu; Enrique Alvarez
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

Review 4.  New immunological approaches in treating and diagnosing CNS diseases.

Authors:  Kathy Guo; Damir Janigro
Journal:  Pharm Pat Anal       Date:  2013-05

5.  MicroRNAs and Multiple Sclerosis.

Authors:  Kemal Ugur Tufekci; Meryem Gulfem Oner; Sermin Genc; Kursad Genc
Journal:  Autoimmune Dis       Date:  2010-11-11

Review 6.  MicroRNAs as novel regulators of neuroinflammation.

Authors:  Dominika Justyna Ksiazek-Winiarek; Magdalena Justyna Kacperska; Andrzej Glabinski
Journal:  Mediators Inflamm       Date:  2013-07-25       Impact factor: 4.711

7.  Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion.

Authors:  Lin-Yuan Zhang; Jiaji Pan; Muyassar Mamtilahun; Yuan Zhu; Liping Wang; Ashwin Venkatesh; Rubing Shi; Xuanqiang Tu; Kunlin Jin; Yongting Wang; Zhijun Zhang; Guo-Yuan Yang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.